Thyrocare Expands Diagnostic Network in Madurai with New Laboratory

It will be supported by trained professionals and the company's technology-enabled processes, with a focus on standardised testing procedures and reliable reporting.

Thyrocare Technologies has expanded its diagnostic network in Tamil Nadu with the launch of a new laboratory in Madurai.

The facility, inaugurated by Rahul Guha, Managing Director and CEO of Thyrocare and API Holdings, is expected to support growing testing requirements across the city and neighbouring regions through technology-enabled diagnostic processes.

The new Madurai laboratory has been equipped to handle both routine and specialised diagnostic testing.

It will be supported by trained professionals and the company's technology-enabled processes, with a focus on standardised testing procedures and reliable reporting.

Through the new facility, Thyrocare aims to strengthen its presence in Madurai and improve access to its diagnostic services for patients and healthcare partners across the surrounding areas.

Rahul Guha, Managing Director and CEO of Thyrocare and API Holdings, said, “At Thyrocare, our focus has always been on making quality and trustworthy diagnostic services more accessible to people across India. The launch of our new laboratory in Madurai is another step towards strengthening our presence in emerging markets and bringing our technology-led diagnostic capabilities closer to patients."

Thyrocare has also recently announced a new laboratory in Jamshedpur, Jharkhand, as part of its expansion into emerging markets.

While the Madurai facility focuses on extending routine and specialised testing access, the company's wider network expansion is intended to serve diverse diagnostic requirements across different regions.

Stay tuned for more such updates on Digital Health News